The method of complex treatment of generalized pain syndromes inorganic origin

 

(57) Abstract:

The invention relates to medicine, and neurology. Sessions are conducted by transcranial electrical stimulation. Previously, a week before the start of the session, every day for 30 minutes before bedtime take antidepressant lerivon. For 40 minutes before the session of electrical stimulation take sirdalud muscle relaxant. After 10 sessions of electrical stimulation to continue taking sirdalud and lerivon. The method improves the efficiency of treatment, reduces the analgesics up to the complete abolition.

The invention relates to medicine, namely, neurology, and is intended for the treatment of patients with generalized pain syndromes inorganic origin. Generalized believe pain syndromes, which capture more than two anatomical areas. Pain was not caused morphological damage to any systems or organs. Such pain, according to the International statistical classification of diseases and problems related to health (10th revision), define as "inorganic" or "psychogenic".

Known methods of treatment of such pain are medication (analgesics, nonsteroidal anti-inflammatory drugs, it is istotnie the waves, ultrasound, warm baths, massage, physiotherapy. (Chronic pain syndromes. Pain is a disease. /Ed. by C. A. Kurshev, Proceedings of VGMI, volume 35, issue. 3, 1984, S. 44-50).

However, the positive effect is achieved only in half of the cases. Patients have long to take analgesics, which leads to side effects.

More pathogenetically justified and the closest to the proposed method is the method of transcranial electrical stimulation endorphin brain structures, which is used for the relief of pain syndromes of various etiologies (Rychkova S. C., Alexander C. A. Transcranial electrostimulation (mechanism of action, analgesic and associated effects) //Questions of balneology, physiotherapy and physical culture. - 1994. N 6. - S. 23-27). The method is based on the activation of antinociceptive system. In the implementation of analgesia involves interrelated opioid, serotonergic and cholinergic mechanisms.

The disadvantage of this method is little impact on the level of depression and tension of skeletal muscles. Although these two factors, combined with the disruption of the antinociceptive system, play an important role is eenie solves the problem of developing a method of complex treatment of patients with generalized pain syndromes inorganic origin.

The technical result consists in increasing the effectiveness of treatment in this group of patients, consisting in the reduction of pain intensity, the reduction in the area of pain and the number of received analgesics, up to their complete abolition. Significantly improved sleep, reduced levels of depression and anxiety, reduces pathologically increased tension of skeletal muscles, stabilizes blood pressure. All this leads to increased physical activity and the health of patients.

This technical result is achieved by the method of complex treatment of generalized pain syndromes inorganic origin, including the implementation of the sessions of transcranial electrostimulation, previously not less than one week before start of session, daily, 30 minutes before bedtime take antidepressant lerivon at a dose of 7.5 mg, through not less than two days, increase the dose by half, and 40 minutes prior to the session of electrical stimulation take the muscle relaxant sirdalud, at a dose of 4 mg after 10 sessions of electrical stimulation to continue taking sirdalud and lerivon up to one month.

The method of complex treatment of generalized pain syndromes near is filling up sessions of transcranial electrostimulation, patients are designated to receive antidepressant lerivon dose, equal to 7.5 mg 30 minutes before bedtime. Not less than two days, the dose of this antidepressant increased twice, i.e., up to 15 mg Given positive effect on sleep, patients begin to experience a positive effect from the first day. To 7 day comes anxiolytic and antidepressant effect. So 8 days begin to run sessions transcranial electrostimulation using the apparatus of Transair-2". This uses current from 3.0 to 5.0 mA depending on individual tolerance of each patient. Sessions of electrical stimulation for 30 minutes every exercise daily for 10 days. And for potentiation of the analgesic, providing direct antinociceptive actions and myorelaxation 40 minutes prior to each session of electrical stimulation patients take the muscle relaxant sirdalud dose is 4 mg After conducting ten sessions of transcranial electrostimulation patients continue to receive sirdalud and lerivon up to one month at the same dose.

Treatment effectiveness was evaluated on the following criteria: the intensity of pain by visual analogue scale (VAS), the area of pain, level geovanie muscular system, control of blood pressure.

In this way treated 32 patients. The efficiency was 84.4 per cent. In the treatment of the control group (28 patients) method of transcranial electrostimulation without drugs effect was observed 64.3% of cases.

Clinical example.

Patient B., 46 years old, was admitted to the neurology ward complaining of constant headaches and pressing nature of the type of "helmets", constant pain in the cervical-thoracic spine, in the left half of the chest and in the left hand to the level of the elbow joint. Under the influence of psycho-emotional factors, weather changes, cold pain increases, wears a belt-like character. Periodic headaches and pain in the cervical spine bothered since 1991, stoped taking analgesics, massage. Since 1994, under the influence of a stressful situation, the pain was generalisability, became a daily. Analgesics for pain relief, and have practically no effect. Within two months began to notice periodic rise in blood pressure up to 150/90 mm RT. senior sharply increased headache, chest pain, fear, anxiety. Disturbed sleep. Neurologically: symptoms of focal lesions of the suboccipital lymphadenopathy muscles, in the neck at C5-C7, in the middle of the upper border of the trapezius muscle. Left trapezius muscle is tense, is palpated active myofascial trigger point.

The patient carried out the treatment by the proposed method. A week before the sessions of transcranial electrostimulation therapy began with the appointment of lerivon dose, equal to 7.5 mg daily 30 minutes before bedtime. Two days after the dose of lerivon increased to 15 mg, 8 days began to run sessions of transcranial electrostimulation using the apparatus of Transair-2". We used the current strength equal to 4.0 mA. Sessions of electrical stimulation for 30 minutes each were carried out daily for 10 days. And for potentiation analiziruyuschego, providing direct antinociceptive actions and myorelaxation 40 minutes prior to each session of electrical stimulation the patient has been sirdalud dose is 4 mg After conducting ten sessions of transcranial electrical stimulation, the patient continued taking sirdalud and lerivon within one month.

Changes in the state of the next. Before treatment: YOUR 5 points; total area of pain - 3523 cm2; level of depression - 28 points; test Spilberger Hanina: reactive anxiety - 2; level of depression - 12 points; test Spilberger Hanina: reactive anxiety - 26 points, personal alarm - 40 points. On palpation of the study increased muscle tension and pain is almost absent. Significantly improved sleep, stabilized blood pressure. Discharged from hospital in satisfactory condition to work.

The method of complex treatment of generalized pain syndromes inorganic origin, including the implementation of the sessions of transcranial electrical stimulation, wherein the pre, at least one week before start of session daily for 30 minutes before bedtime take antidepressant lerivon at a dose of 7.5 mg, through not less than two days, increase the dose by half, and for 40 minutes before the session of electrical stimulation take the muscle relaxant sirdalud in a dose of 4 mg after 10 sessions of electrical stimulation to continue taking sirdalud and lerivon up to one month.

 

Same patents:

The invention relates to the field of medicine and medical equipment and can be used for the treatment of diseases based on the pathogenesis of which is the formation of stagnant pockets of excitation or inhibition in the cortex of the cerebral hemispheres, and can be used for the treatment of nervous and mental diseases, psychosomatic diseases, removal of reactive States, as well as in drug for the treatment of various addictions, such as food, alcohol, drugs, drugs, tobacco, etc
The invention relates to medicine, namely to dentistry
The invention relates to medicine, and is intended for the treatment of gallstone disease
The invention relates to medicine, and is intended for the treatment of urolithiasis

The invention relates to the field of medical equipment, electronic devices, electrical stimulation of the human body, and is intended for non-invasive impacts on areas of skin of a person by electric impulses in order to assist the General regulating influence on the physiological systems of the body and achieve an analgesic effect

The invention relates to the field of agriculture, division of animal health, and in particular to methods and devices for electrical stimulation of the muscles of the abdomen and uterus in animals with pathological childbirth (weak contractions and attempts, retention of placenta)

The invention relates to medicine, namely to anesthesiology, and can be used in anesthetic ensuring operations in patients with organic lesions of the brain
The invention relates to medicine, neurology

The invention relates to medical equipment, namely to gastroenterocolitis used principally for the recovery of motor-evacuation function of the gastrointestinal tract in the early postoperative period

The invention relates to medicine, addiction

The invention relates to medicine, namely to the device to determine the temperature and perform the stimulation of organs and tissues in obstetrics and gynecology, dentistry, and is intended for the diagnosis of health status before and after treatment, and for prevention and treatment of inflammatory and other diseases
The invention relates to medicine, namely to vertebrology, neurology, neurosurgery

The invention relates to medical technology, and is intended for the treatment of several diseases of the nervous, cardiovascular, muscular, dental systems and skin
The invention relates to medicine, pulmonology
The invention relates to ophthalmology
Up!